Skip to content

Outcomes Associated With Suicidality in Inpatients With Symptoms of Depression (OASIS-D)

Patient Characteristics, Validity of Clinical Diagnoses and Outcomes Associated With Suicidality in Inpatients With Symptoms of Depression (OASIS-D)

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04404309
Acronym
OASIS-D
Enrollment
3331
Registered
2020-05-27
Start date
2020-08-01
Completion date
2024-12-31
Last updated
2024-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression, Depression Moderate, Depression Severe, Suicidal and Self-injurious Behavior, Suicidal Ideation, Suicide, Attempted

Keywords

Depression, Suicidality

Brief summary

This 6-month, naturalistic cohort study examines male and female inpatients aged 18 to 75 years i) with any form of unipolar depressive episode (cohort 1); ii) clinical diagnosis of a moderate or severe unipolar depressive episode and suicidal tendencies who agree to participate in a prospective study (cohort 2); and moderate or severe unipolar depressive episodes validated by research interviews and and suicidal tendencies that persist for at least 48 hours after admission who are followed up for 6 months (cohort 3).

Detailed description

Epidemiological cross-sectional study in over 3000 inpatients with a clinical diagnosis of major depressive disorder, validation of the clinical diagnosis in 520 patients, and prospective naturalistic 6-month follow-up study of 260 adults with a research interview-confirmed major depressive disorder, with data collection at the following points: at T0 = time of hospitalization (epidemiological study population 1 with data from clinical routine practice), at time T1 of baseline survey in patients with persistent suicidal tendencies, i.e. at least 48 hours after T0 (study population 2 as a subgroup of study population 1, with study information and consent), and in study population 3 (subgroup of study population 2, with study information and consent) at the time of discharge (T2), 3 months after admission to hospital (T3/ by telephone) and 6 months after inpatient admission (T4). The aim of the study is to characterize the remission or recurrence of suicidal symptoms in the context of a depressive episode. It is expected that the results will help to improve the understanding of the disease process and the further development of effective intervention options.

Interventions

None listed

Sponsors

Janssen-Cilag G.m.b.H
CollaboratorINDUSTRY
Charite University, Berlin, Germany
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

For Population 1 1.any form of unipolar depressive episode For Population 2 1. clinical diagnosis of a moderate or severe unipolar depressive episode 2. clinically diagnosed suicidal tendencies that persist for at least 48 hours after admission to hospital 3. Written consent to participate in the study For Population 3 1. Diagnosis of a moderate or severe unipolar depressive disorder through the structured research interview Mini International Neuropsychiatric Interview (M.I.N.I.) 2. Suicidality with a value \> / = 1 for item 2 (passive suicidality) OR item 3 (active suicidality) based on the research interview Sheehan Suicidality Tracking Scale (S-STS) 3. Written consent to participate in the study

Exclusion criteria

* Patients younger than 18 years or older than 75 years * No clinical diagnosis of a depressive episode * Depressive episode in the context of a bipolar disorder- secondary depression as a result of physical illness or substance use * severe physical symptoms of disease that make participation in the study impossible * Pregnancy * not being able to understand the study processes * incapable of giving informed consent * no authorization to give consent due to (limited) incapacity

Design outcomes

Primary

MeasureTime frameDescription
Sheehan Suicidality Tracking Scale (S-STS)20 minInterview for Suicidality, Suicidal Behavior and Suicide Attempts, the higher the value the worse the outcome, the values can range from 0- 156
Mini-International Neuropsychiatric Interview (M.I.N.I.)40 minSemi-structured interview for research diagnosis

Secondary

MeasureTime frameDescription
Montgomery-Asberg Depression Rating Scale (MADRS)20 minStructured Interview for Symptoms of Depression
Clinical Global Impression of Resolution Suicide Risk (CGI-SR-R)1 minOne Question rated by an interviewer
Clinical Global Impression of Imminent Suicide Risk (CGI-SR-I)1 minOne Question rated by an interviewer
Service Use and Resource Form (SURF)30 minStructured Interview for Service Use of the health care system
Clinical Global Impression - Change (CGI-C)1 minOne Question about change of the symptoms rated by an interviewer
Young Mania Rating Scale (YMRS)20 minStructured Interview for Mania Symptoms
Clinical Global Impression - Severity (CGI-S)1 minOne Question about severity of illness, rated by an interviewer
Adherence Questions5 minSemi Structured Interview for Adherence of Antipsychotics

Countries

Germany

Contacts

Primary ContactChristoph U Correll, MD
christoph.correll@charite.de+49-30-450

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026